Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-12

Clinical Trial Update: A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to evaluate whether Survodutide helps Japanese people living with obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Survodutide (BI456906)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Obesity | Phase 3 | Status: COMPLETED